Real-time, in vivo rodent imaging, allows researchers to observe and monitor several normal and abnormal biological processes. Data collected using the eyes series, provides crucial initial insights and generate quantitative results that, in combination with the Visual | eyesTM interface, compose an essential platform for every preclinical laboratory.
Oncology
Non-invasively assess your agent's targeting properties, real-time monitor drug delivery and track tumor progression.
Infection, Inflammation
Acquire detailed insights into disease mechanisms, enhance more accurate diagnostics while supporting the development or improvement of new or already existing therapeutics.
Protocol optimization
Test different animal preparation conditions, drug concentrations and administration routes to optimize your protocols.
Quick insights
Scan the same mouse at multiple time points to determine the optimal moments for 3D imaging. Conduct super-fast QC to exclude faulty injected subjects from further and more complex studies.
Applications with eyes™
Cardiac PET, Stroke
Cardiac PET imaging using ¹⁸F-FDG
Cardiac PET imaging in a mouse model of myocardial infarction. Image info: 80 min post injection - 20 min scan - total injected dose 6 MBq
Oncology, alpha-emitters, SPECT
Study of Tumour Uptake using a ²²⁵Ac-Labeled FAPI-Targeting Agent
This study investigates the tumour uptake of a ²²⁵Ac-labeled FAPI-targeting compound in a HEK-FAP xenograft mouse model. In vivo SPECT imaging was performed using BIOEMTECH’s γ-eye™ system and was carried out on 3 characteristic energy peaks of ²²⁵Ac. Image info: Scan duration 20 min. Dose injected: 5.14 μCi / 0.19 MBq. Images acquired at BIOEMTECH Laboratories.
PET
Using Zr-89 for lungs imaging
In vivo imaging of free Zr-89 accumulation in the lungs of a healthy mouse following intratracheal administration. Imaging parameters: 30 min post-administration static acquisition - injected activity 94.4 μCi - acquisition time 5min.